Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Prospective Collection of Biological Samples From Patients With Rare Neurological Diseases

ID
Name
RC31/20/0150
Description
The aim of this project is to improve biological collections of patients presenting rare neurological disorders with known or suspected autoimmune origin. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies.
Trial arms
Trial start
2020-10-12
Estimated PCD
2030-01-01
Trial end
2030-09-03
Status
Recruiting
Treatment
Blood collection on admission and longitudinally
Biological samples will be collected in the normal diagnosis and follow-up process. Only blood will be taken in larger quantity (8 tubes of 7mL).
Arms:
patients with rare autoimmune neurological diseases
Size
1000
Primary endpoint
Building a collection of biological samples and clinical-biological data from patients with rare autoimmune neurological diseases
Day 0 and through study completion, an average of 1 year
Eligibility criteria
Inclusion Criteria: * all patients with neurological disorders, with known or probable autoimmune involvement. This includes adults and children and peripheral and/or central nervous system symptoms. * Social coverage up to date. Exclusion Criteria: * Patients with neurological damage from which the autoimmune character can be excluded. * Known anemia and hemoglobin \<10 g / dl * Patients under protective supervision (guardianship, curators) * Pregnant or breastfeeding woman
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 1000, 'type': 'ESTIMATED'}}
Updated at
2023-07-24

1 organization

1 product

1 indication

Organization
University Hospital of Toulouse
Product
Blood collection
Indication
Nervous System Diseases